Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» infants
infants
Maternal RSV vaccines found to cut infection risk
Axios
Thu, 01/23/25 - 11:42 am
RSV
vaccines
Pfizer
Abrysvo
infants
Merck targets 2025 RSV season with antibody now under FDA review
BioPharma Dive
Wed, 12/18/24 - 11:09 am
Merck
RSV
clesrovimab
infants
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Reuters
Thu, 10/17/24 - 08:39 pm
Merck
clesrovimab
RSV
clinical trials
infants
Merck claims late-stage study success for RSV antibody
BioPharma Dive
Tue, 07/23/24 - 11:36 am
Merck
RSV
infants
clesrovimab
antibdodies
New ‘One-And-Done’ Vaccine Method Could Protect Infants—From Covid, Flu—With Just A Single Shot, Study Suggests
Forbes
Mon, 04/15/24 - 09:35 pm
vaccines
universal vaccines
infants
siRNA
Widespread use of Pfizer's maternal RSV shot would reduce costs and prevent infant hospitalizations: study
Fierce Pharma
Wed, 10/11/23 - 11:52 pm
Pfizer
RSV
vaccines
pregnancy
infants
FDA approves Pfizer’s RSV vaccine for use in pregnancy
BioPharma Dive
Mon, 08/21/23 - 08:02 pm
Pfizer
RSV
vaccines
infants
FDA
Abrysvo
pregnancy
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
Stat
Thu, 08/3/23 - 06:34 pm
CDC
RSV
infants
monoclonal antibodies
Sanofi
Beyfortus
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Mon, 07/17/23 - 07:00 pm
Sanofi
AstraZeneca
Beyfortus
nirsevimab
RSV
infants
pediatric
FDA
Pfizer RSV vaccine seen as effective against severe disease, FDA documents say
Stat
Tue, 05/16/23 - 10:33 pm
Pfizer
RSV
vaccines
infants
pregnancy
FDA
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Fri, 05/12/23 - 10:16 am
Sanofi
AstraZeneca
RSV
antibodies
infants
clinical trials
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Motley Fool
Thu, 05/11/23 - 10:55 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
infants
FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old
Yahoo/Reuters
Thu, 12/8/22 - 10:06 am
Pfizer
BioNTech
Moderna Therapeutics
FDA
COVID-19
vaccines
infants
pediatric
Britain's health regulator backs COVID vaccine for infants from six months
Yahoo/Reuters
Tue, 12/6/22 - 10:27 am
UK
COVID-19
vaccines
infants
pediatric
Pfizer
BioNTech
Sanofi, AstraZeneca win EMA support for RSV drug in babies
BioPharma Dive
Sun, 09/18/22 - 10:22 pm
AstraZeneca
Beyfortus
RSV
Europe
pediatric
infants
Pfizer's 20-valent pneumococcal vaccine hits goal in infant trial, teeing up 2022 approval filing
Fierce Biotech
Fri, 08/12/22 - 10:16 am
Pfizer
vaccines
Prevnar 20
FDA
infants
clinical trials
pneumococcal disease
DBV patches up prospects with phase 3 win in infants with peanut allergies
Fierce Biotech
Wed, 06/8/22 - 10:15 am
DBV Technologies
peanut allergy
clinical trials
infants
Vertex cystic fibrosis drug gets expanded approval for use in infants
Reuters
Thu, 08/16/18 - 10:18 am
FDA
Vertex Pharmaceuticals
Kalydeco
infants
cystic fibrosis